
Midday Stock Roundup: Rookie stock Liminatus up 16%
July 23: HEALTHCARE Liminatus Pharma Inc. (Nasdaq: LIMN) is up 16% to $6.70 a share with a market cap of $177 million. The La Palma-based preclinical-stage biopharmaceutical company, which went public in May via a SPAC, said yesterday that it is exploring …